STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. today announced the initiation and first participant enrollment in a Phase 1 clinical study that will examine pharmacokinetic properties of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback